Severe late esophagus toxicity in NSCLC patients treated with IMRT and concurrent chemotherapy

Radiotherapy and Oncology

Volumn 108, Issue 2, 2013, Pages 337-341

  Chen, Chun ^a   Uyterlinde, Wilma ^a   Sonke, Jan Jakob ^a   De Bois, Josien ^a   Van Den Heuvel, Michel ^a   Belderbos, José ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Acute esophagus toxicity; Concurrent chemoradiation; IMRT; Late esophagus toxicity; Non small cell lung cancer (NSCLC); NTCP

Indexed keywords

CETUXIMAB; CISPLATIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; ESOPHAGUS DISEASE; ESOPHAGUS FISTULA; ESOPHAGUS PERFORATION; ESOPHAGUS STENOSIS; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LATE ESOPHAGUS TOXICITY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION;

ACUTE ESOPHAGUS TOXICITY; CONCURRENT CHEMORADIATION; IMRT; LATE ESOPHAGUS TOXICITY; NON SMALL CELL LUNG CANCER (NSCLC); NTCP;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CHEMORADIOTHERAPY; CISPLATIN; COHORT STUDIES; ESOPHAGUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NETHERLANDS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 84885381445     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.08.017     Document Type: Article

References (19)

1. M. Kwint, W. Uyterlinde, and J. Nijkamp Acute esophagus toxicity in lung cancer patients after intensity modulated radiation therapy and concurrent chemotherapy Int J Radiat Oncol Biol Phys 84 2012 223 228
2. M. Partridge, M. Ramos, and A. Sardaro Dose escalation for non-small cell lung cancer: analysis and modelling of published literature Radiother Oncol 99 2011 6 11
3. W. Uyterlinde, C. Chen, and M. Kwint Prognostic parameters for acute esophagus toxicity in intensity modulated radiotherapy and concurrent chemotherapy for locally advanced non-small cell lung cancer Radiother Oncol 107 2013 392 397 [Epub 2013 May 3]
4. J.L.L. Guerra, D. Gomez, and Q. Wei Association between single nucleotide polymorphisms of the transforming growth factor β1 gene and the risk of severe radiation esophagitis in patients with lung cancer Radiother Oncol 105 2012 299 304
5. R.W. Byhardt, C. Scott, and W.T. Sause Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung Int J Radiat Oncol Biol Phys 42 1998 469 478
6. A.L. Uitterhoeve, J.S. Belderbos, and M.G. Koolen Toxicity of high-dose radiotherapy combined with daily cisplatin in non-small cell lung cancer: results of the EORTC 08,912 phase I/II study. European Organization for Research and Treatment of Cancer Eur J Cancer 36 2000 592 600
7. R. Komaki, W. Seiferheld, and D. Ettinger Randomized phase II chemotherapy and radiotherapy trial for patients with locally advanced inoperable non-small-cell lung cancer: long-term follow-up of RTOG 92-04 Int J Radiat Oncol Biol Phys 53 2002 548 557
8. J. Belderbos, L. Uitterhoeve, and N. van Zandwijk Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973) Eur J Cancer 43 2007 114 121
9. A. van Baardwijk, B. Reymen, and S. Wanders Mature results of a phase II trial on individualised accelerated radiotherapy based on normal tissue constraints in concurrent chemo-radiation for stage III non-small cell lung cancer Eur J Cancer 48 2012 2339 2346
10. S.J. Ahn, D. Kahn, and S. Zhou Dosimetric and clinical predictors for radiation-induced esophageal injury Int J Radiat Oncol Biol Phys 61 2005 335 347
11. J. Belderbos, W. Uyterlinde, and A. Vincent OC-0498 concurrent chemoradiotherapy with or without cetuximab in NSCLC; toxicity results of a randomized phase II trial Radiother Oncol 103 2012 S200
12. A. Niemierko Reporting and analyzing dose distributions: a concept of equivalent uniform dose Med Phys 24 1997 103 110
13. J.T. Lyman Complication probability as assessed from dose-volume histograms Radiat Res Suppl 8 1985 13 19
14. J. Nijkamp, M. Rossi, and J. Lebesque Relating acute esophagitis to radiotherapy dose using FDG-PET in concurrent chemo-radiotherapy for locally advanced non-small cell lung cancer Radiother Oncol 106 2013 118 123
15. B. Emami, J. Lyman, and A. Brown Tolerance of normal tissue to therapeutic irradiation Int J Radiat Oncol Biol Phys 21 1991 109 122
16. W. Dorr, and J.H. Hendry Consequential late effects in normal tissues Radiother Oncol 61 2001 223 231
17. P.D. Maguire, G.S. Sibley, and S.M. Zhou Clinical and dosimetric predictors of radiation-induced esophageal toxicity Int J Radiat Oncol Biol Phys 45 1999 97 9103
18. J. Bradley, J.O. Deasy, and S. Bentzen Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma Int J Radiat Oncol Biol Phys 58 2004 1106 1113
19. D Clayton, and M. Hills Chapters 3 and 13 Statistical models in epidemiology 1993 Oxford University Press New York